6505-01-289-9826 ( NDC57706-0756-23 , NDC00093-9411-01 , NDC00603-4470-21 , NDC00781-1072-01 , NEPTAZANE , NEPTAZANE TABLETS )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-289-9826 6505 012899826 METHAZOLAMIDE TABLETS,USP 2822
NSN Features
MRC Parameter Characteristics
SUPP SUPPLEMENTARY FEATURES MEDSEP ITEM FOR DOD,AMERICAN CYANAMID,LEDERLE LABS DIV
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY METHAZOLAMIDE TABLETS USP 25MG 100S BT
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 25.000 MILLIGRAMS METHAZOLAMIDE ACTIVE INGREDIENT
CQCT PRIMARY CONTAINER TYPE BOTTLE
CRLK PRIMARY CONTAINER CONTENT QUANTITY 100.000 TABLETS
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC57706-0756-23 06404 A 2 3 4 ZZ
NDC00093-9411-01 80608 A 2 5 4 ZZ
NDC00603-4470-21 0ET99 A 2 5 4 ZZ
NDC00781-1072-01 71115 A 2 5 4 ZZ
NEPTAZANE 06404 A 1 5 4 KX
NEPTAZANE TABLETS 06404 A 1 5 4 KX
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC57706-0756-23 06404 AMERICAN CYANAMID CO A A
NDC00093-9411-01 80608 LEMMON CO A A
NDC00603-4470-21 0ET99 GENERICS BIDCO I LLC F A
NDC00781-1072-01 71115 BRISTOL-MYERS CO A A
NEPTAZANE 06404 AMERICAN CYANAMID CO A A
NEPTAZANE TABLETS 06404 AMERICAN CYANAMID CO A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 12/03/1 P 3004909165 2822
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DA C2201X- A K U/I CONTAINS 100 TT
DN 9B----- N K U/I CONTAINS 100 TT
DS I K U/I CONTAINS 100 TT
DF ------- F K U/I CONTAINS 100 TT
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DN SMS L 1 BT Q U 9B----- N
DS SMS L 1 BT Q U D
DF SMS L 1 BT Q U ------- F
DA SMS L 1 BT Q U C2201X- A
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC